First PPI Bellwether Trial Set to Begin on Sept. 21, 2020

Introduction

As per the U.S. District Court, District of New Jersey court order released on June 20, 2018, the first bellwether trial for the kidney injury lawsuits against Nexium and other PPI manufacturers will convene on September 21, 2020.

Over 4,500 lawsuits are federally-filed against PPI manufacturers over claims that the heartburn drugs Nexium, Prilosec, Prevacid, Protonix, and Dexilant cause kidney complications. Plaintiffs accuse the drug makers of failing to provide adequate warnings to doctors and patients about the potential risks of the drugs. Lawsuits claim adverse events of renal malfunctions including Acute interstitial nephritis, Acute kidney injury, Chronic kidney disease, and Kidney failure. PPI lawsuits were centralized as part of the multidistrict litigation (MDL No. 2789; In Re: Proton-Pump Inhibitor Products Liability Litigation [No. II]) overlooked by Judge Claire C. Cecchi in the District of New Jersey.

Comments

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

First PPI Bellwether Trial Set to Begin on Sept. 21, 2020